MTOR and glioblastoma: These events were also accompanied by the suppression of the mitogen activated protein/extracellular signal-regulated kinase (MAPK)/ERK pathway, suggesting that mTOR inhibition may affect EGFR ability to endorse GBM cell survival and proliferation.